Oncology Spotlight: Exploring CRT, Immunotherapy and AI in cancer care with Prof. Gerry Hanna

Описание к видео Oncology Spotlight: Exploring CRT, Immunotherapy and AI in cancer care with Prof. Gerry Hanna

Welcome to the Oncology Spotlight! In this episode, join us as we delve into the forefront of cancer care with Professor Gerry Hanna, a distinguished radiation oncologist and Marie Curie Chair of Clinical Oncology at Trinity College Dublin.

Key Discussion Points:

Introduction: Get to know Professor Gerry Hanna and his illustrious career spanning leading institutions like Queen’s University Belfast and the University of Melbourne.

Latest Developments in Lung Cancer Treatment: Professor Hanna shares groundbreaking advancements shaping the future of lung cancer care.

Evolution of CRT in Lung Cancer: Discover insights into how Combined
Radiation Therapy (CRT) has progressed over the past five years.

Interpreting Scans Post-CRT: Learn about challenges and strategies in interpreting scans, especially in conjunction with immunotherapy.

Emerging Guidelines for Scan Interpretation: Professor Hanna outlines emerging best practices crucial for accurate treatment decisions.

Role of Multidisciplinary Teams (MDT): Understand the pivotal role MDTs play in enhancing diagnostic accuracy and treatment planning.

Current Research Initiatives: Explore ongoing research projects like PERTAIN and CONCORDE and their potential impact on cancer care.

Challenges in Oncology Today: Professor Hanna discusses the significant challenges facing oncology and strategies to overcome them.

Future Prospects with AI: Gain insights into the promising intersection of oncology and artificial intelligence (AI).

Don't miss this enlightening conversation that promises to deepen your understanding of cutting-edge oncology practices and future directions in cancer treatment.

🎧 Listen to the full podcast episode: https://podcasters.spotify.com/pod/sh...[…]rapy-and-AI-in-cancer-care-with-Prof--Gerry-Hanna-e2md8i8 and join the conversation!

Комментарии

Информация по комментариям в разработке